News

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...
Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in ...
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...
One-year clinical trial data for the next-generation, investigational, Sphere-360TM single-shot PFA catheter show impressive safety, perf ...
PFA therapy works differently from traditional cardiac ablation approaches by delivering high energy electrical pulses to targeted areas of cardiac t ...
PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...
Kardium Inc., a private medical device company that's advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed ...
Patients with a high probability of HFpEF may experience greater benefits from atrial fibrillation ablation than those with a ...
Boston Scientific Corporation today announced positive 12-month primary endpoint results from the second phase of the ...
Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...